Prefilled syringe eliminates the need to reconstitute separate vials prior to administration and simplifies the vaccine process.

The U.S. Food and Drug Administration has approved GSK's prefilled syringe presentation of Shingrix (zoster vaccine recombinant, adjuvanted) for the prevention of shingles (herpes zoster).

The prefilled syringe presentation is licensed in the United States for immunization of adults 50 years and older, as well as those aged 18 years and older who are or will be at increased risk for ...

The prefilled syringe presentation of GSK’s shingles vaccine is also undergoing regulatory review by the European Medicines Agency (EMA), with filing acceptance received in January 2025, marking ...

The company added that the prefilled syringe presentation of GSK's shingles vaccine is also undergoing regulatory review by the European Medicines Agency.

The prefilled syringe presentation of Shingrix does not require reconstitution.

The FDA has approved a prefilled syringe option of Shingrix which will streamline administration of GSK’s herpes zoster vaccine for adult patients.

GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved a prefilled syringe presentation of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted) for the ...

The prefilled syringe formulation is the first DHE auto-injector that patients can self-administer in a ready-to-use form, according to Amneal. The injector does not require refrigeration ...

Andembry is available as a single-use prefilled auto-injector and a single-dose prefilled syringe. Recommended dosage Your doctor will prescribe the dosage of Andembry that’s right for you.

FDA raised safety concerns for Vyvgart Hytrulo in CIDP, while Argenx moves ARGX-119 into late-stage trials for rare neuromuscular disease.